Infrequent activation of mitogen-activated protein kinase in human colon cancers

Hepato-Gastroenterology

Volumn 46, Issue 29, 1999, Pages 2831-2834

  Sakakura, Chouhei ^a   Hagiwara, Akeo ^a   Shirahama, Tsutomu ^b   Nakanishi, Masayoshi ^a   Yasuoka, Rie ^a   Fujita, Yoshifumi ^a   Inazawa, Johji ^a   Abe, Tatsuo ^a   Kohno, Michiharu ^c   Yamagishi, Hisakazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c NONE

Author keywords

Colon cancer; Mitogen activated protein kinase

Indexed keywords

GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ADVANCED CANCER; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CLINICAL ARTICLE; COLON CANCER; ENZYME ACTIVITY; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN CELL; ONCOGENE K RAS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CELL TRANSFORMATION, NEOPLASTIC; COLON; COLONIC NEOPLASMS; DNA MUTATIONAL ANALYSIS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION;

EID: 0032697753     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1 Marshall CJ: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80:179-185.
2. 2 Nishida E, Gotoh Y: The MAP kinase cascade is essential for diverse signal transduction pathway. TIBS 1993;18:128-131.
3. 3 Gille H, Sharrocks AD, Shaw PE: Phosphorylation of transcription factor p62TCF by MAP kinase stimulates tertiary complex formation at c-fos promoter. Nature 1992; 358:414-417.
4. 4 Sturgill TW, Ray CB, Erickson E, Maller JL: Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1998; 334:715-718.
5. 5 Lin T-A, Kong X, Haystead TA, Pause A, Belsham G, Sonenberg N, Lawrence JC Jr: PHAS-1 as a link between mitogen-activated protein kinase and translation initiation. Science 1994; 266:653-656.
6. 6 Cowley S, Paterson H, Kemp P, Marshall CJ: Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH3T3 cells. Cell 1994; 77:841-852.
7. 7 Leevers SJ, Marshall CJ: Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein. EMBOJ 1992; 11:569-574.
8. 8 Dent P, Haser W, Haystead TA, Vincent LA, Roberts TM, Sturgill TW: Activation of mitogen-activated protein kinase by v-Rαf in NIH 3T3 Cells and in vitro. Science 1992; 257:1404-1407.
9. 9 Sakakura C, Igarashi Y, Hakomori S: Plasmalopsychosine of human brain mimics the effect of nerve growth factor by activating its receptor kinase and mitogen-activated protein kinase in PC12 cells. J Biol Chem 1996; 271:946-952.
10. 10 Oka H, Chatani Y, Hoshino B, Ogawa O, Kakehi Y, Terachi T, Okada Y, Kawaichi M, Kohno M, Yoshida O: Constitutive activation of Mitogen-Activated Protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995; 55:4182-4187.
11. 11 Marx, J: Two major signal pathways linked. Science 1993; 262: p. 988.
12. 12 Hunter T: Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 1995; 80:225-236.
13. 13 Zhang Y, Saez R, Leal MA, Chan AM: Synergism between two growth regulatory pathways: cooperative transformation of NIH3T3 cells by G alpha 12 and c-rαf-1. Oncogene 1996; 6:2377-2383.
14. 14 Licato LL, Keku TO, Wurzelmann JI, Murray SC, Woosley JT, Sandler RS, Brenner DA: In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia. Gastroenterology 1997; 113:1589-1598.
15. 15 Attar BM, Atten MJ, Holian O: MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. Anticancer Res 1996; 16:395-399.
16. 16 Posada J, Yew N, Ahn NG, Vande Woude GF, Cooper JA: Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase in vivo. Mol Cell Biol 1993; 13:2546-2553.
17. 17 Lange-Carter CA, Pleiman CM, Gardner AM, Blumer KJ, Johnson GL: A divergence in the MAF kinase regulatory network defined by MEK kinase and Rαf. Science 1993; 260:315-319.